Everything about Raw Materials
“The existing situation has exposed some structural weaknesses while in the EU’s medicines provide chain and also a higher dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides claimed. She advised that supply chain difficulties be tackled